Latest Annual Reports
by Mike Gee
12 June 2026









































AIR INDUSTRIES GROUP
REVENUE
$47,921,000
-13.04%
INCOME
-$1,305,000
4.47%
EMPLOYEES
160
CUSTOMERS
4
Manufacturer of precision components and assemblies for aerospace and defense prime contractors, supplying landing gears, flight controls, engine mounts and related parts to U.S. and international governments and commercial airlines.
View Company PageFiled: 2026-03-27
BUDA JUICE, INC.
REVENUE
$12,609,000
11.84%
INCOME
$3,533,000
-1.15%
EMPLOYEES
39
CUSTOMERS
1
Buda Juice, Inc. is a Texas-based producer of always-cold, cold-crafted citrus juices, lemonades, and wellness shots operating an end-to-end 35°F cold-chain platform with organic, non-organic and private-label lines and a regional retail expansion strategy.
View Company PageFiled: 2026-03-26
Apex Treasury Corp
REVENUE
N/A
INCOME
-$12,731,957
EMPLOYEES
N/A
CUSTOMERS
N/A
Apex Treasury Corporation is a Cayman Islands blank-check company (SPAC) formed in June 2025 that holds IPO proceeds in a trust account to complete a business combination within 24 months and has no operations or revenue to date.
View Company PageFiled: 2026-03-26
Beach Acquisition Co Parent, LLC
REVENUE
$8,969,351,000
12.11%
INCOME
$639,471,000
17.16%
EMPLOYEES
22,300
CUSTOMERS
N/A
Beach Acquisition, after acquiring Skechers in September 2025, operates Skechers as a global footwear, apparel, and accessories brand with Wholesale and Direct-to-Consumer segments, a large international store and distribution network, outsourced manufacturing through independent contract suppliers, and a diversified global footprint across approximately 180 countries.
View Company PageFiled: 2026-03-26
BlackRock Monticello Debt Real Estate Investment Trust
REVENUE
$16,929,000
INCOME
-$2,293,000
EMPLOYEES
N/A
CUSTOMERS
N/A
BlackRock Monticello Debt Real Estate Investment Trust is an externally managed Maryland statutory trust (formed Nov 7, 2024) conducting a continuous blind-pool private offering to originate, acquire, finance, manage and dispose of primarily U.S. real estate debt investments while seeking REIT taxation beginning in 2025.
View Company PageFiled: 2026-03-26
Aptevo Therapeutics Inc.
REVENUE
N/A
INCOME
-$25,967,000
-7.61%
EMPLOYEES
36
CUSTOMERS
N/A
Clinical-stage biotechnology company developing immunotherapy candidates for cancer using its ADAPTIR and ADAPTIR-FLEX platform technologies.
View Company PageFiled: 2026-03-26
ACTUATE THERAPEUTICS, INC.
REVENUE
N/A
INCOME
-$22,227,852
18.54%
EMPLOYEES
12
CUSTOMERS
N/A
Actuate Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing elraglusib, a GSK-3β inhibitor (IV and oral) for hard-to-treat cancers including metastatic pancreatic cancer and pediatric sarcomas.
View Company PageFiled: 2026-03-26
AB Private Credit Investors Corp
REVENUE
$181,782,245
5.00%
INCOME
$53,302,131
-20.76%
EMPLOYEES
N/A
CUSTOMERS
N/A
AB Private Credit Investors Corporation is an externally managed, non-diversified closed-end Business Development Company that primarily originates and invests in privately negotiated U.S. middle-market loans to generate current income and preserve capital.
View Company PageFiled: 2026-03-26
Acumen Pharmaceuticals, Inc.
REVENUE
N/A
INCOME
-$121,335,000
-18.57%
EMPLOYEES
61
CUSTOMERS
N/A
Acumen Pharmaceuticals is a clinical-stage biopharmaceutical company developing sabirnetug (ACU193), an antibody that selectively targets soluble amyloid-β oligomers to slow progression of early Alzheimer's disease.
View Company PageFiled: 2026-03-26
AmpliTech Group, Inc.
REVENUE
$25,195,930
164.99%
INCOME
-$7,007,155
37.67%
EMPLOYEES
47
CUSTOMERS
7
AmpliTech Group Inc. is a Nevada-based designer, manufacturer and distributor of RF/microwave amplifiers, MMICs and semiconductor packaging, providing custom RF subsystems and 5G ORAN solutions to aerospace, defense, satellite and telecom customers.
View Company PageFiled: 2026-03-26
BioRestorative Therapies, Inc.
REVENUE
$359,700
-10.30%
INCOME
-$14,200,000
-58.14%
EMPLOYEES
14
CUSTOMERS
N/A
BioRestorative Therapies develops adult stem cell–based therapies for disc/spine (BRTX-100) and metabolic (ThermoStem) indications, operates a cell-based bio-cosmeceutical platform, and is advancing clinical development while seeking additional financing.
View Company PageFiled: 2026-03-26
Arcadia Biosciences, Inc.
REVENUE
$4,858,000
-3.71%
INCOME
-$2,300,000
67.14%
EMPLOYEES
8
CUSTOMERS
N/A
Arcadia is a Dallas-based consumer goods company that markets Zola coconut water, focuses on science-based product development, and has divested most of its wheat trait IP while facing financing and tariff-related challenges.
View Company Page